Neuro-oncology
ATIM-27. PHASE I INVESTIGATION OF LENALIDOMIDE PLUS RITUXIMAB AND OUTCOMES OF LENALIDOMIDE MAINTENANCE IN RECURRENT CNS LYMPHOMA.
Neuro-oncology
Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER Consortium.
Neuro-oncology
Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma.
Neuro-oncology
Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice.
Neuro-oncology